7048

524669

HESTERBIO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

HESTER BIOSCIENCES LTD Share Price Today

HESTER BIOSCIENCES LTD is currently trading at ₹2110, down by ₹39.1 from the previous close. The stock touched an intraday high of ₹2193.00 and a low of ₹2097.20 during the latest trading session. Over the past one year, HESTER BIOSCIENCES LTD has delivered a return of 22.15%, while the stock has gained 14.6% in the last one month.

HESTER BIOSCIENCES LTD performance

Today’s low Today’s high
₹ 2097.20 ₹ 2193.00
₹ 2118.30
52 week low 52 week high
₹ 1239.30 ₹ 2350.00
₹ 2118.30
Open Price ₹ 2151.00
Prev. Close ₹ 2149.10
Volume (Shares) 5942.00
Total traded value ₹ 125.86
Upper Circuit ₹ 2578.90
Lower Circuit ₹ 1719.30
info

Investment Returns

Over 1 Month 14.60% Over 3 Months 59.44% Over 6 Months 35.76% Over 1 Year 22.15%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

HESTER BIOSCIENCES LTD fundamentals


  • Market cap (Cr) 1,804.30
  • P/E Ratio (TTM) 34.84
  • Beta 0.54
  • Book Value / share 452.78
  • Return on equity 14.39%
  • EPS (TTM) 55.27
  • Dividend yield 0.52%
  • Net profit/quarter (Cr) 26.38
info icon alternate text
  • Market cap (Cr) 1,794.90
  • P/E Ratio (TTM) 34.84
  • Beta 0.51
  • Book Value / share 452.78
  • Return on equity 14.39%
  • EPS (TTM) 55.27
  • Dividend yield 0.52%
  • Net profit/quarter (Cr) 26.38
info icon alternate text

HESTER BIOSCIENCES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 93.71
Operating Expense 70.01
Net Profit 26.38
Net Profit Margin (%) 28.15
Earnings Per Share (EPS) 31.01
EBITDA 42.63
Effective Tax Rate (%) 24.34
Particulars DEC 2025 (Values in Cr)
Revenue 70.35
Operating Expense 56.75
Net Profit 10.67
Net Profit Margin (%) 15.16
Earnings Per Share (EPS) 12.54
EBITDA 17.75
Effective Tax Rate (%) 27.11
Particulars SEP 2025 (Values in Cr)
Revenue 64.58
Operating Expense 56.17
Net Profit 7.21
Net Profit Margin (%) 11.16
Earnings Per Share (EPS) 8.48
EBITDA 13.35
Effective Tax Rate (%) 27.02
Particulars JUN 2025 (Values in Cr)
Revenue 63.49
Operating Expense 54.15
Net Profit 7.84
Net Profit Margin (%) 12.34
Earnings Per Share (EPS) 9.21
EBITDA 13.36
Effective Tax Rate (%) 23.80
Particulars MAR 2025 (Values in Cr)
Revenue 76.67
Operating Expense 66.25
Net Profit 9.64
Net Profit Margin (%) 12.57
Earnings Per Share (EPS) 11.33
EBITDA 14.76
Effective Tax Rate (%) 16.11
Particulars MAR 2026 (Values in Cr)
Revenue 292.14
Operating Expense 237.08
Net Profit 52.10
Net Profit Margin (%) 17.83
Earnings Per Share (EPS) 61.24
EBITDA 87.10
Effective Tax Rate (%) 25.22
Particulars MAR 2025 (Values in Cr)
Revenue 286.47
Operating Expense 249.47
Net Profit 31.84
Net Profit Margin (%) 11.11
Earnings Per Share (EPS) 37.43
EBITDA 55.70
Effective Tax Rate (%) 23.75
Particulars MAR 2024 (Values in Cr)
Revenue 285.16
Operating Expense 252.68
Net Profit 27.16
Net Profit Margin (%) 9.52
Earnings Per Share (EPS) 31.93
EBITDA 51.59
Effective Tax Rate (%) 26.05
Particulars MAR 2023 (Values in Cr)
Revenue 254.00
Operating Expense 215.40
Net Profit 32.34
Net Profit Margin (%) 12.73
Earnings Per Share (EPS) 38.02
EBITDA 60.21
Effective Tax Rate (%) 26.36
Particulars MAR 2022 (Values in Cr)
Revenue 219.35
Operating Expense 170.75
Net Profit 39.52
Net Profit Margin (%) 18.01
Earnings Per Share (EPS) 46.45
EBITDA 65.22
Effective Tax Rate (%) 25.79
Particulars MAR 2026 (Values in Cr)
Book Value / Share 423.46
ROE % 17.04
ROCE % 14.56
Total Debt to Total Equity 0.60
EBITDA Margin 31.76
Particulars MAR 2025 (Values in Cr)
Book Value / Share 369.41
ROE % 9.51
ROCE % 8.86
Total Debt to Total Equity 0.76
EBITDA Margin 22.20
Particulars MAR 2024 (Values in Cr)
Book Value / Share 343.00
ROE % 7.41
ROCE % 8.74
Total Debt to Total Equity 0.91
EBITDA Margin 22.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 328.82
ROE % 10.39
ROCE % 9.01
Total Debt to Total Equity 0.93
EBITDA Margin 26.37
Particulars MAR 2022 (Values in Cr)
Book Value / Share 305.61
ROE % 16.17
ROCE % 13.29
Total Debt to Total Equity 0.69
EBITDA Margin 31.55
Particulars MAR 2026 (Values in Cr)
Book Value / Share 452.78
ROE % 14.39
ROCE % 15.28
Total Debt to Total Equity 0.25
EBITDA Margin 29.81
Particulars MAR 2025 (Values in Cr)
Book Value / Share 398.60
ROE % 9.77
ROCE % 9.47
Total Debt to Total Equity 0.36
EBITDA Margin 19.45
Particulars MAR 2024 (Values in Cr)
Book Value / Share 367.59
ROE % 8.98
ROCE % 8.51
Total Debt to Total Equity 0.49
EBITDA Margin 18.10
Particulars MAR 2023 (Values in Cr)
Book Value / Share 343.70
ROE % 11.53
ROCE % 11.52
Total Debt to Total Equity 0.51
EBITDA Margin 23.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share 315.54
ROE % 15.62
ROCE % 17.26
Total Debt to Total Equity 0.27
EBITDA Margin 29.74
Particulars MAR 2026 (Values in Cr)
Cash & Short Term Investments 6.53
Total Assets 677.94
Total Liabilities 677.94
Total Equity 367.78
Share Outstanding 0
Price to Book Ratio 2.79
Return on Assets (%) 8.20
Return on Capital (%) 10.01
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 7.21
Total Assets 653.38
Total Liabilities 653.38
Total Equity 326.65
Share Outstanding 0
Price to Book Ratio 3.15
Return on Assets (%) 4.20
Return on Capital (%) 5.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 15.30
Total Assets 662.34
Total Liabilities 662.34
Total Equity 302.87
Share Outstanding 0
Price to Book Ratio 3.78
Return on Assets (%) 2.85
Return on Capital (%) 3.49
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 14.81
Total Assets 669.96
Total Liabilities 669.96
Total Equity 288.54
Share Outstanding 0
Price to Book Ratio 4.42
Return on Assets (%) 3.97
Return on Capital (%) 4.78
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 25.20
Total Assets 562.16
Total Liabilities 562.16
Total Equity 267.39
Share Outstanding 0
Price to Book Ratio 8.61
Return on Assets (%) 6.99
Return on Capital (%) 8.03
Particulars MAR 2026 (Values in Cr)
Cash & Short Term Investments 4.56
Total Assets 557.34
Total Liabilities 557.34
Total Equity 385.18
Share Outstanding 0
Price to Book Ratio 2.79
Return on Assets (%) 9.34
Return on Capital (%) 11.33
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.17
Total Assets 545.99
Total Liabilities 545.99
Total Equity 339.08
Share Outstanding 0
Price to Book Ratio 3.15
Return on Assets (%) 5.83
Return on Capital (%) 7.18
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.96
Total Assets 549.54
Total Liabilities 549.54
Total Equity 312.71
Share Outstanding 0
Price to Book Ratio 3.78
Return on Assets (%) 4.94
Return on Capital (%) 6.09
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.96
Total Assets 545.81
Total Liabilities 545.81
Total Equity 292.38
Share Outstanding 0
Price to Book Ratio 4.42
Return on Assets (%) 5.92
Return on Capital (%) 7.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.98
Total Assets 424.44
Total Liabilities 424.44
Total Equity 268.43
Share Outstanding 0
Price to Book Ratio 8.61
Return on Assets (%) 9.31
Return on Capital (%) 10.12
Particulars MAR 2026 (Values in Cr)
Net Income 75.83
Cash from Operations 78.26
Cash from Investing -2.86
Cash from Financing -48.79
Net change in Cash -2.82
Free Cash Flow 96.09
Particulars MAR 2025 (Values in Cr)
Net Income 39.57
Cash from Operations 75.98
Cash from Investing -19.00
Cash from Financing -51.71
Net change in Cash -6.72
Free Cash Flow 96.57
Particulars MAR 2024 (Values in Cr)
Net Income 31.95
Cash from Operations 59.84
Cash from Investing -22.60
Cash from Financing -26.09
Net change in Cash -0.35
Free Cash Flow 84.24
Particulars MAR 2023 (Values in Cr)
Net Income 40.15
Cash from Operations 31.70
Cash from Investing -76.99
Cash from Financing 41.75
Net change in Cash -11.59
Free Cash Flow 109.46
Particulars MAR 2022 (Values in Cr)
Net Income 53.50
Cash from Operations 25.82
Cash from Investing -116.58
Cash from Financing 111.53
Net change in Cash 3.48
Free Cash Flow 121.53
Particulars MAR 2026 (Values in Cr)
Net Income 69.68
Cash from Operations 64.41
Cash from Investing -2.36
Cash from Financing -48.31
Net change in Cash 0.24
Free Cash Flow 81.73
Particulars MAR 2025 (Values in Cr)
Net Income 41.76
Cash from Operations 73.89
Cash from Investing -19.04
Cash from Financing -46.35
Net change in Cash -1.42
Free Cash Flow 94.52
Particulars MAR 2024 (Values in Cr)
Net Income 36.73
Cash from Operations 53.89
Cash from Investing -20.58
Cash from Financing -24.12
Net change in Cash -1.84
Free Cash Flow 76.26
Particulars MAR 2023 (Values in Cr)
Net Income 43.92
Cash from Operations 41.42
Cash from Investing -71.96
Cash from Financing 41.37
Net change in Cash 2.77
Free Cash Flow 114.07
Particulars MAR 2022 (Values in Cr)
Net Income 53.25
Cash from Operations 32.34
Cash from Investing -110.58
Cash from Financing 94.96
Net change in Cash 0.28
Free Cash Flow 123.01
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.60 13.06 1.52 242.16 23.12 38.85
BLISS GVS PHARMA LTD. 473.30 38.42 4.20 5019.64 118.35 493.70
CIPLA LTD 1415.30 30.04 3.32 114334.35 1165.55 1672.20
FERMENTA BIOTECH LTD. 341.80 15.08 2.47 1005.95 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.60 22.10 4.07 242.16 23.12 38.85
AMRUTAJAN HEALTH LTD 546.80 24.51 4.26 1580.83 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8556.55 111.75 24.50 21391.38 7630.00 9850.00
BLISS GVS PHARMA LTD. 473.30 51.06 4.34 5019.64 118.35 493.70

HESTER BIOSCIENCES LTD shareholding pattern

Holding
45.88%
53.73%
0.37%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

HESTER BIOSCIENCES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
2121.00 -1.30 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 2082.40
  • 26 Days 1949.50
  • 10 Days 2044.90
  • 50 Days 1834.20
  • 12 Days 2032.70
  • 100 Days 1728.50
  • 20 Days 1984.80
  • 200 Days 1726.40
2134.67 PIVOT
First Support 2094.33 First Resistance 2189.43 Second Support 2039.57 Second Resistance 2229.77 Third Support 1999.23 Third Resistance 2284.53
RSI 71.85 ADX 75.38 MACD 83.20 Williams % R -9.78 Commodity Channel Index (CCI) 159.08
Date 2026-06-22 Week 4384.00 Same Day 7798.00 Month 5437.00
1 Year 0.54 3 Year 0.73
Over 1 Month
14.60% down
Over 1 Year
22.15% down
Over 3 Months
59.44% down
Over 3 Years
8.56% down
Over 6 Months
35.76% down
Over 5 Years
-3.90% down

HESTER BIOSCIENCES LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
14 Jul 2026 11.0 Final 14 Jul 2026 Equity shares
06 Aug 2025 7.0 Final 06 Aug 2025 Equity shares
22 Aug 2024 6.0 Final 23 Aug 2024 Equity shares
13 Sep 2023 8.0 Final 14 Sep 2023 Equity shares
11 Aug 2022 10.0 Final 12 Aug 2022 Equity shares
05 Aug 2021 10.0 Final 07 Aug 2021 Equity shares
27 Aug 2020 6.6 Final 29 Aug 2020 Equity shares
18 Jul 2019 7.0 Final 20 Jul 2019 Equity shares
09 Nov 2018 2.0 Interim 2 12 Nov 2018 Equity shares
30 Aug 2018 2.0 Interim 1 31 Aug 2018 Equity shares
02 Aug 2018 6.0 Final 04 Aug 2018 Equity shares
16 Nov 2017 4.0 Interim 17 Nov 2017 Equity shares
20 Jul 2017 2.3 Final 22 Jul 2017 Equity shares
03 Nov 2016 3.0 Interim 04 Nov 2016 Equity shares
21 Jul 2016 1.1 Final 23 Jul 2016 Equity shares
17 Mar 2016 3.0 Interim 18 Mar 2016 Equity shares
10 Sep 2015 3.1 Final 12 Sep 2015 Equity shares
18 Sep 2014 2.0 Final 20 Sep 2014 Equity shares
07 Aug 2013 2.0 Final 10 Aug 2013 Equity shares
27 Aug 2012 1.0 Final 28 Aug 2012 Equity shares
25 Aug 2011 3.5 Final 27 Aug 2011 Equity shares
22 Jul 2010 3.0 Final 24 Jul 2010 Equity shares
13 Aug 2009 2.5 Final 15 Aug 2009 Equity shares
21 Aug 2008 2.5 Final 23 Aug 2008 Equity shares
06 Sep 2007 2.0 Final 08 Sep 2007 Equity shares
06 Jun 2005 0.0 Final 08 Jun 2005 Equity shares
Ex-Date Ex-Bonus Ratio
29 Sep 2012 27 Sep 2012 1:2
Dividend date Dividend amount Dividend type Record date Instrument type
14 Jul 2026 11.0 Final 14 Jul 2026 Equity shares
06 Aug 2025 7.0 Final 06 Aug 2025 Equity shares
22 Aug 2024 6.0 Final 23 Aug 2024 Equity shares
13 Sep 2023 8.0 Final 14 Sep 2023 Equity shares
11 Aug 2022 10.0 Final 12 Aug 2022 Equity shares
05 Aug 2021 10.0 Final 07 Aug 2021 Equity shares
27 Aug 2020 6.6 Final 29 Aug 2020 Equity shares
18 Jul 2019 7.0 Final 20 Jul 2019 Equity shares
09 Nov 2018 2.0 Interim 2 12 Nov 2018 Equity shares
30 Aug 2018 2.0 Interim 1 31 Aug 2018 Equity shares
02 Aug 2018 6.0 Final 04 Aug 2018 Equity shares
16 Nov 2017 4.0 Interim 17 Nov 2017 Equity shares
20 Jul 2017 2.3 Final 22 Jul 2017 Equity shares
03 Nov 2016 3.0 Interim 04 Nov 2016 Equity shares
21 Jul 2016 1.1 Final 23 Jul 2016 Equity shares
17 Mar 2016 3.0 Interim 18 Mar 2016 Equity shares
10 Sep 2015 3.1 Final 12 Sep 2015 Equity shares
18 Sep 2014 2.0 Final 20 Sep 2014 Equity shares
07 Aug 2013 2.0 Final 10 Aug 2013 Equity shares
27 Aug 2012 1.0 Final 28 Aug 2012 Equity shares
25 Aug 2011 3.5 Final 27 Aug 2011 Equity shares
22 Jul 2010 3.0 Final 24 Jul 2010 Equity shares
13 Aug 2009 2.5 Final 15 Aug 2009 Equity shares
21 Aug 2008 2.5 Final 23 Aug 2008 Equity shares
06 Sep 2007 2.0 Final 08 Sep 2007 Equity shares
06 Jun 2005 0.0 Final 08 Jun 2005 Equity shares
Ex-Date Ex-Bonus Ratio
29 Sep 2012 27 Sep 2012 1:2

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Hester Biosciences Ltd?

Answer Field

Hester Biosciences Ltd share price is for NSE ₹ 2,110.00 & for BSE ₹ 2,104.50 as on Jun 23 2026 03:29 PM.

What is the Market Cap of Hester Biosciences Ltd Share?

Answer Field

The market cap of Hester Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 23 2026 03:29 PM.

What is the 52 Week High and Low of Hester Biosciences Ltd?

Answer Field

The 52 Week High and Low of Hester Biosciences Ltd for NSE is ₹ 2,350.00 and ₹ 1,239.30 and for BSE is ₹ 2,347.70 and ₹ 1,250.95.

What is 1 year return for Hester Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been 22.15%.

What is the P/E Ratio of Hester Biosciences Ltd Share?

Answer Field

As on Jun 23 2026 03:29 PM the price-to-earnings (PE) ratio for Hester Biosciences Ltd share is 34.84.

What is the PB ratio of Hester Biosciences Ltd Share?

Answer Field

As on Jun 23 2026 03:29 PM, the price-to-book (PB) ratio for Hester Biosciences Ltd share is 452.78.

How to Buy Hester Biosciences Ltd Share?

Answer Field

You can trade in Hester Biosciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Hester Biosciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Hester Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Hester Biosciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|